Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Krishnan Mahesh
Over the trailing 90 days, Krishnan Mahesh (Director at HALOZYME THERAPEUTICS, INC.) traded $829K of stock (net selling $267K) in HALO, per 5 SEC Form 4 transactions.
- Role
- Director
- Companies
- HALO
- Window
- Trailing 90 days · 5 transactions · CIK 1866746
- Net activity
- −$267K ($281K bought · $548K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | 5 | $281K | $548K | −$267K |
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-29 | HALO | Sell | 7.3K | $0 | Exercise or conversion of derivative security |
| 2026-06-29 | HALO | Sell | 7.3K | $548K | Open market or private sale |
| 2026-06-29 | HALO | Buy | 7.3K | $281K | Exercise or conversion of derivative security |
| 2026-05-05 | HALO | Buy | 3.8K | $0 | Grant, award or other acquisition |
| 2026-05-05 | HALO | Buy | 6.0K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Krishnan's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.